Ingersoll Rand Beats Q3 Earnings Estimates, Raises Revenue Guidance

Ingersoll Rand’s Q3 2026 adjusted EPS rose 24.4% to $1.07, beating estimates by 20.2%, while revenue increased 5.6% to $2.06 billion and orders climbed 20.7% to $2.35 billion. Free cash flow rose to $623.3 million from $325.5 million year over year. The company raised 2026 revenue-growth guidance to 5.5–7% from 4.5–6.5% and adjusted EPS guidance to $3.58–$3.70 from $3.45–$3.57, while maintaining adjusted EBITDA guidance of $2.13–$2.19 billion.

Analysis

The signal is better in demand than in realized economics. IR’s order growth and book-to-bill support revenue visibility over the next several quarters, but the large infrastructure award could make the headline order pace lumpy; validate conversion, timing, and cancellation terms before extrapolating it. More importantly, reported EBITDA margin expansion reverses to contraction excluding tariff refunds, while EBITDA guidance was held. That divergence makes the earnings-guide increase less clean than the headline suggests: verify the EPS-to-EBITDA bridge, including interest, taxes, and share count, rather than assuming operating leverage.

The revenue-guide raise is also not equivalent to a comparable organic acceleration: management’s organic-growth range remains modest, with acquisitions and FX contributing to the outlook. FCF is strong, but the >100% conversion claim includes ILC Dover-related recoveries; the company’s roughly 95% ex-recovery outlook is the more useful recurring benchmark. Buybacks may support per-share results, but should not obscure underlying margin performance.

For the next 1–3 months, orders and conversion are the catalyst; over 6–18 months, sustained organic growth and recovery in ex-refund margins determine whether the stronger order book merits a higher quality multiple. Dover’s reported growth offers some broad industrial-demand corroboration, while Graco’s small estimate miss is a weaker counter-signal; these are not clean like-for-like read-throughs. Consensus may overvalue the EPS beat and cash-flow spike while underweighting the margin split and inorganic/FX contribution. No valuation data are supplied, so avoid assuming the beat is mispriced.

Key Decisions for Investors

• IR: avoid chasing the earnings reaction; consider a staged long on post-event weakness only if order conversion remains healthy and ex-refund margins stabilize. Falsify the thesis on a material book-to-bill deterioration, weaker organic guidance, or further ex-refund margin contraction.
• Relative-value watch: long IR versus short GGG only as a measured industrial-momentum spread, not a broad sector call. IR has stronger disclosed order momentum; GGG’s modest miss alone is not enough to establish a short. Reassess if GGG reports improving demand or IR’s orders fail to convert.
• Over the next 1–3 months, track project-award conversion and backlog progression, plus the EPS-versus-EBITDA guidance bridge. If the EPS uplift depends materially on non-operating factors while EBITDA remains flat, reduce confidence in durable operating leverage.
• Use recurring FCF conversion near the ex-recovery outlook as the baseline; treat the reported quarter’s elevated conversion as non-recurring until the ILC Dover-related recoveries and working-capital contribution are separately verified.